OPTINOSE INC. - COMMO

Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference

22 11 2023 08:00:00 提供 Nasdaq GlobeNewswire

Optinose Reports Third Quarter 2023 Financial Results and Operational Updates

09 11 2023 06:00:00 提供 Nasdaq GlobeNewswire

Optinose Announces Reporting Date for Third Quarter 2023 Financial Results

27 10 2023 07:00:00 提供 Nasdaq GlobeNewswire

Optinose to Present at the 2023 Cantor Global Healthcare Conference

22 9 2023 08:01:00 提供 Nasdaq GlobeNewswire

Optinose Reports Second Quarter 2023 Financial Results and Operational Updates

10 8 2023 06:00:00 提供 Nasdaq GlobeNewswire

Optinose Announces Preliminary Second Quarter 2023 XHANCE Net Revenue of $19.5 Million

27 7 2023 06:00:01 提供 Nasdaq GlobeNewswire

Optinose Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

16 6 2023 15:08:00 提供 Nasdaq GlobeNewswire

Optinose to Present at the Jefferies Healthcare Conference

02 6 2023 12:00:00 提供 Nasdaq GlobeNewswire

Optinose Reports First Quarter 2023 Financial Results and Operational Updates

11 5 2023 06:00:18 提供 Nasdaq GlobeNewswire

Optinose Announces FDA Acceptance of Supplemental New Drug Application for XHANCE

04 5 2023 06:00:01 提供 Nasdaq GlobeNewswire

Optinose Announces Reporting Date for First Quarter 2023 Financial Results

01 5 2023 15:30:00 提供 Nasdaq GlobeNewswire

Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

18 4 2023 07:00:01 提供 Nasdaq GlobeNewswire

Optinose to Present at the Needham Virtual Healthcare Conference

12 4 2023 15:00:00 提供 Nasdaq GlobeNewswire

Optinose Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Operational Highlights

07 3 2023 06:00:56 提供 Nasdaq GlobeNewswire

Optinose Announces Reporting Date for Fourth Quarter 2022 Financial Results

28 2 2023 15:30:00 提供 Nasdaq GlobeNewswire

Optinose Submits Supplemental New Drug Application for XHANCE Label Expansion

21 2 2023 06:00:01 提供 Nasdaq GlobeNewswire

Optinose Announces CEO Transition and Business Update

31 1 2023 06:00:01 提供 Nasdaq GlobeNewswire

Optinose Appoints Paul Spence as Chief Commercial Officer

15 12 2022 15:30:00 提供 Nasdaq GlobeNewswire

Optinose Announces Departure of Acting Chief Financial Officer

09 12 2022 07:00:00 提供 Nasdaq GlobeNewswire

Optinose Announces Corporate Updates and Presentation at the 34th Annual Piper Sandler Healthcare Conference

30 11 2022 06:00:00 提供 Nasdaq GlobeNewswire